» Articles » PMID: 38112416

Variations in the Oral Microbiome and Metabolome of Methamphetamine Users

Overview
Journal mSystems
Specialty Microbiology
Date 2023 Dec 19
PMID 38112416
Authors
Affiliations
Soon will be listed here.
Abstract

Drug addiction can seriously damage human physical and mental health, while detoxification is a long and difficult process. Although studies have reported changes in the oral microbiome of methamphetamine (METH) users, the role that the microbiome plays in the process of drug addiction is still unknown. This study aims to explore the function of the microbiome based on analysis of the variations in the oral microbiome and metabolome of METH users. We performed the 16S rRNA sequencing analysis based on the oral saliva samples collected from 278 METH users and 105 healthy controls (CTL). In addition, the untargeted metabolomic profiling was conducted based on 220 samples. Compared to the CTL group, alpha diversity was reduced in the group of METH users and the relative abundances of and were significantly increased, while the relative abundances of and were significantly decreased. Variations were also detected in oral metabolic pathways, including enhanced tryptophan metabolism, lysine biosynthesis, purine metabolism, and steroid biosynthesis. Conversely, the metabolic pathways of porphyrin metabolism, glutathione metabolism, and pentose phosphate were significantly reduced. It was speculated that four key microbial taxa, i.e., , , , and , could be involved in the toxicity and addiction mechanisms of METH by affecting the above metabolic pathways. It was found that with the increase of drug use years, the content of tryptamine associated with neuropsychiatric disorders was gradually increased. Our study provides novel insights into exploring the toxic damage and addiction mechanisms underlying the METH addiction.IMPORTANCEIt was found that with the increase of drug use years, the content of tryptamine associated with neuropsychiatric disorders gradually increased. The prediction models based on oral microbiome and metabolome could effectively predict the methamphetamine (METH) smoking. Our study provides novel insights into the exploration of the molecular mechanisms regulating the toxic damage and addiction of METH as well as new ideas for early prevention and treatment strategies of METH addiction.

References
1.
Fujakova-Lipski M, Kaping D, Sirova J, Horacek J, Palenicek T, Zach P . Trans-generational neurochemical modulation of methamphetamine in the adult brain of the Wistar rat. Arch Toxicol. 2017; 91(10):3373-3384. DOI: 10.1007/s00204-017-1969-y. View

2.
Wu J, Wang K, Wang X, Pang Y, Jiang C . The role of the gut microbiome and its metabolites in metabolic diseases. Protein Cell. 2020; 12(5):360-373. PMC: 8106557. DOI: 10.1007/s13238-020-00814-7. View

3.
Carabotti M, Scirocco A, Maselli M, Severi C . The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015; 28(2):203-209. PMC: 4367209. View

4.
Godino A, Jayanthi S, Cadet J . Epigenetic landscape of amphetamine and methamphetamine addiction in rodents. Epigenetics. 2015; 10(7):574-80. PMC: 4622560. DOI: 10.1080/15592294.2015.1055441. View

5.
McClure-Begley T, Roth B . The promises and perils of psychedelic pharmacology for psychiatry. Nat Rev Drug Discov. 2022; 21(6):463-473. DOI: 10.1038/s41573-022-00421-7. View